{"id":"W2118779298","doi":"10.1016/s1470-2045(15)70081-1","title":"Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":333,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Université de Montréal; University of Colorado Denver; Leids Universitair Medisch Centrum; Centre Léon Bérard; Università degli Studi di Padova; Università Cattolica del Sacro Cuore; Erasmus Medisch Centrum; Astellas Pharma; University of Miami","keywords":"Medicine; Tolerability; Adrenocortical carcinoma; Clinical endpoint; Placebo; Internal medicine; Population; Oncology; Carcinoma; Clinical trial; Adverse effect; Surgery; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001676311,0.002143168,0.004563405,0.0005916063,0.0005166117,0.001241312,0.001059993,0.002107044,0.00875298],"category_scores_gemma":[0.001500169,0.001191871,0.002605109,0.000553565,0.001910451,0.001537009,0.0005207232,0.003863309,0.00160451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008462657,"about_ca_system_score_gemma":0.001138048,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00148271,"about_ca_topic_score_gemma":0.002848688,"domain_scores_codex":[0.9993743,0.0003135416,0.00004118363,0.0001149917,0.00004400302,0.0001119506],"domain_scores_gemma":[0.9992446,0.0002202897,0.0001517018,0.00006157163,0.00004368166,0.0002781034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9881207,0.002244478,0.0001173425,0.0004813339,0.0004862901,0.00001492935,0.00002875682,0.0001659829,0.001740841,0.00005422618,0.0003072541,0.006237888],"study_design_scores_gemma":[0.9670917,0.03155674,0.000423924,0.00001774387,0.0002424997,0.00001302366,0.00001358269,0.0001699905,0.0001467218,0.00008077286,0.0002315608,0.00001163041],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9765667,0.00990353,0.001468686,0.0010647,0.001435202,0.004963287,0.001447334,0.0003523509,0.002798256],"genre_scores_gemma":[0.9807075,0.005306932,0.001934284,0.001471622,0.000691311,0.003527669,0.0008249287,0.00006149811,0.005474322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00875298,"threshold_uncertainty_score":0.02928162,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1504030667974675,"score_gpt":0.411612096007158,"score_spread":0.2612090292096905,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}